Fertility options in Mayer-Rokitansky-Küster-Hauser syndrome

Background: The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is the most common cause of uterine aplasia, with a worldwide frequency 1 in 4500 females. Although abundant literature present regarding different available methods for creating neovagina MRKH syndrome, attention dedicated to these women’s reproductive potential remains insufficient. Methods: Online searches were carried out PubMed database during November and December 2020. search included combination various terms (e.g., MRKH, vaginoplasty, uterus transplantation, infertility treatment, gestational surrogacy, etc.). following inclusion criteria used: (1) articles should be written English or French language. (2) article have been published by an official scientific organization. Results: Until few years ago, only option women was legal adoption, now surrogacy (GS) transplantation (UTx) become new fertility options patients. Discussion: GS officially recognized several countries widely practiced. On other hand, UTx, although great recent technical improvements, far from being all secondary its complexity necessary immunologic therapies.